Objectives-To establish if advice concerning risks of pregnancy when taking oral contraceptive pill and antibiotics is being offered. Method-A retrospective audit of notes of 100 female patients aged 15-39 who were prescribed antibiotics. Results-Documentation of use of contraception was noted in 3% of patients. Advice concerning risks and further precautions was noted in this 3% but not in any other records. Conclusion-The audit identified a gap in documentation and/or clinical practice in advising women of childbearing age of the risk of conceiving when using oral contraceptive pill and antibiotics. Recommendations are given as to how this may be addressed. (7 Accid Emerg Med 1999; 16:268-270) 
Since the introduction in 1960 of the oral contraceptive pill (OCP) its use increased steadily until the late 1970s and levelled off thereafter, possibly due to publication of reports detailing adverse effects. There are an estimated 60 million users of the "pill" world wide' and in Britain 39% of women aged 15-39 were found to be taking the OCP. ' The OCP prevents conception by exerting a negative feedback on secretion of follicle stimulating hormone and luteinising hormone. This prevents development of graafian follicles and subsequent ovulation. In addition, high concentrations of oestrogens and progestins produce alterations in the genital tract and endometrium that may contribute to the contraceptive effectiveness of these preparations. 3 Although more than 85% of couples who are sexually active claim to be using some method of contraception, it is known that up to one third of pregnancies can be unplanned. The failure rate of the OCP is very small, between 0-1 %4 and is often attributed to one of the following:
* Patient forgetting to take the OCP. * Gastroenteritis impairing absorption. * Drugs, for example phenytoin, increasing the metabolic activity of the liver and causing increased elimination of contraceptive steroids.
* Concomitant administration of antibiotics and the OCP.
It is this last point that we discuss and explore in this audit.
The first clinical report of interaction between the OCP and antibiotics appeared in 1971 when it was observed that there was an increased incidence of intermenstrual bleeding in women who were reliably taking the OCP and rifampicin (for treatment of tuberculosis).'
In the absence of identifying a local cause responsible, intermenstrual bleeding is often regarded as a warning signal of loss of contraceptive efficacy if it has not occurred previously in the same woman on the same OCP.
Subsequent studies showed that pregnancy was the only major reported adverse incident related to the use of antibiotics and the OCP; the most commonly involved antibiotics being ampicillin, co-trimoxazole, and the tetracyclines. 6 Back et al undertook a data analysis of the records of the Committee on Safety of Medicines in the UK between 1968 and 1984 and identified 63 pregnancies reported in women taking the OCP and antibiotics, with penicillin and tetracyclines being the most frequently cited.7 They observed that this was likely to be a small percentage of the true incidence due to under-reporting.
There are several theoretical mechanisms for the association of failed OCP and antibiotic treatment8:
* Rifampicin has been shown experimentally to increase the hepatic enzymes that accelerate the elimination of oestrogen and progestin compounds from plasma by forming inactive metabolites.
* Antibiotics that alter either the load or nature of bacterial flora in the gut may reduce absorption of the OCP.
* Although experimental data are scant and conflicting, there is a suggestion that an increase in gut motility could reduce the absorption time and may lead to increased excretion of, for example, erythromycin.
* There is evidence that women taking the lower dose OCP may be at particular risk of critical falls in circulating steroid concentrations.
The clinical significance of the association needs to be considered. Your doctor has prescribed you antibiotics which are necessary to treat the infection. However the antibiotics can interfere with the pill and make it less effective. This means that you may not be protected from pregnancy if you have sex, even though you are taking the pill.
You are advised that you should take additional precautions, that is use a condom, during the time that you are taking the antibiotics, and for 7 days after completing the course of antibiotics.
If this runs into your pill free week you must start a new packet IMMEDIATELYand continue without a break until your new pill free week, after which you can continue to take the pill as normal.
If you are at all worried about this advice contact either your own general practitioner, the local family planning clinic, or the accident and emergency department. Remember, it is important that you complete your course of antibiotics as prescribed. while on the OCP, official figures do not bear this out, perhaps due to under-reporting. While the exact figures are not known the medicolegal and human cost should not be underestimated.
Staff in the A&E department need to be aware of this association and be encouraged to improve documentation and the giving of information in order to minimise the risk. This should be reinforced with written information to advise patients how to minimise the risk and prevent an unwanted pregnancy.
